Symptomatic benign prostatic hyperplasia (BPH) in men w/ enlarged prostate to improve symptoms, reduce the risk of acute urinary retention & the need for BPH-related surgery.
May reduce serum prostate-specific antigen conc & increase the risk of high-grade prostate cancer development. Men should not donate blood until at least 6 mth following the last dose. Hepatic impairment. Risk to male fetus, should not be handled by a woman who is pregnant or who could become pregnant.
Sign Out
